ATE531381T1 - Stabilisierte reiskleiederivate zur behandlung von diabetes - Google Patents

Stabilisierte reiskleiederivate zur behandlung von diabetes

Info

Publication number
ATE531381T1
ATE531381T1 AT98944602T AT98944602T ATE531381T1 AT E531381 T1 ATE531381 T1 AT E531381T1 AT 98944602 T AT98944602 T AT 98944602T AT 98944602 T AT98944602 T AT 98944602T AT E531381 T1 ATE531381 T1 AT E531381T1
Authority
AT
Austria
Prior art keywords
stabilized rice
diabetes
derivatives
treatment
rice cloth
Prior art date
Application number
AT98944602T
Other languages
English (en)
Inventor
Patricia Mcpeak
Rukmini Cheruvanky
Reddy Cherukuri
Original Assignee
Ricex Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricex Company Inc filed Critical Ricex Company Inc
Application granted granted Critical
Publication of ATE531381T1 publication Critical patent/ATE531381T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/115—Cereal fibre products, e.g. bran, husk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
AT98944602T 1997-08-29 1998-08-28 Stabilisierte reiskleiederivate zur behandlung von diabetes ATE531381T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5740997P 1997-08-29 1997-08-29
PCT/US1998/017953 WO1999010002A1 (en) 1997-08-29 1998-08-28 A method for treating diabetes, hyperglycemia and hypoglycemia

Publications (1)

Publication Number Publication Date
ATE531381T1 true ATE531381T1 (de) 2011-11-15

Family

ID=22010415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98944602T ATE531381T1 (de) 1997-08-29 1998-08-28 Stabilisierte reiskleiederivate zur behandlung von diabetes

Country Status (12)

Country Link
US (1) US6303586B1 (de)
EP (1) EP1011702B1 (de)
JP (1) JP2001513571A (de)
KR (1) KR100583211B1 (de)
CN (1) CN1114438C (de)
AT (1) ATE531381T1 (de)
AU (1) AU751704B2 (de)
BR (1) BR9811426A (de)
CA (1) CA2305665C (de)
MX (1) MXPA00002122A (de)
NZ (1) NZ503648A (de)
WO (1) WO1999010002A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9209898A (en) * 1997-09-02 1999-03-22 Ricex Company, Inc., The A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
US6716451B1 (en) * 1999-11-30 2004-04-06 Soft Gel Technologies, Inc. Formulation and delivery method to enhance antioxidant potency of vitamin E
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
IL147942A0 (en) * 2002-01-31 2002-08-14 Enzymotec Ltd Method of fractionation of phytosterol esters in oil and products obtained thereby
KR100496019B1 (ko) * 2002-07-19 2005-06-16 대한민국 혈당 저하 효과를 가지는 감마 오리자놀
US7329688B2 (en) * 2002-12-17 2008-02-12 Soft Gel Technologies, Inc. Natural vitamin E compositions with superior antioxidant potency
US20060233863A1 (en) * 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
JP2006232670A (ja) * 2003-05-20 2006-09-07 Ajinomoto Co Inc 神経障害用薬剤
JP4846990B2 (ja) * 2003-08-06 2011-12-28 株式会社テラ・ブレインズ アディポネクチン分泌促進剤
WO2005032478A2 (en) * 2003-10-01 2005-04-14 Yasoo Health, Inc. Treatment for diabetic microvascular and macrovascular complications
US20070254055A1 (en) * 2003-11-21 2007-11-01 Trustees Of Tufts College Therapeutic Avenanthramide Compounds
US20050239892A1 (en) * 2003-11-21 2005-10-27 Trustees Of Tufts College Therapeutic avenathramide compounds
US20060100274A1 (en) * 2004-11-05 2006-05-11 Trustees Of Tufts College Therapeutic avenanthramide compounds
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
AU2005270825B2 (en) * 2004-08-09 2011-07-07 Enzymotec Ltd. Food products for diabetics
WO2006016363A2 (en) * 2004-08-10 2006-02-16 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US20060083700A1 (en) * 2004-10-18 2006-04-20 Naturri Llc Use of a novel phytonutrient rich bioactive concentrate (Ri-ActiveTM) for the prevention and treatment of cardiovascular disease, diabetes and other health disorders
CN104306367A (zh) * 2004-11-08 2015-01-28 爱科来株式会社 过氧化物酶体增殖物激活受体活化剂及其用途
KR100665628B1 (ko) * 2005-01-17 2007-01-10 (주)내츄럴엔도텍 Ｄｐｐ-ⅳ 활성 억제 및 혈당 강하용 조성물
EP2194140A2 (de) 2005-03-02 2010-06-09 Metanomics GmbH Verfaheren zur Herstellung von Feinchemikalien
US7259075B2 (en) * 2005-03-03 2007-08-21 Nec Electronics Corporation Method for manufacturing field effect transistor
US9179687B2 (en) 2005-03-30 2015-11-10 Board Of Trustees Of The University Of Arkansas Yeast fermentation of rice bran extracts
US20060240156A1 (en) * 2005-04-26 2006-10-26 Joseph Panarisi Enhancing kit for comestible products
KR101361603B1 (ko) * 2005-09-05 2014-02-12 쯔노 푸드 인더스트리얼 컴퍼니 리미티드 체내 지질 개선 조성물
CN100356983C (zh) * 2005-11-18 2007-12-26 山东大学 胃肠造影剂用生物质的生物技术处理方法
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
EP2012598A1 (de) * 2006-04-13 2009-01-14 Naturi LLC Konzentrate mit hohem biowirkstoffgehalt, und nährprodukte und therapeutika, die diese enthalten
US9034919B2 (en) 2006-04-18 2015-05-19 Kartik Natarajan Bioactive-rich concentrates and nutritive and therapeutic products containing same
US8084065B2 (en) * 2006-05-29 2011-12-27 Fenchem Enterprises, Ltd Compositions for treating and preventing hyperlipidemia
CN101156679B (zh) * 2006-10-02 2011-07-20 何建国 米糠营养原液及其制作方法
ITMI20062031A1 (it) * 2006-10-23 2008-04-24 Velleja Res Srl Composizioni per la prevenzione del depauperamento della flora intestinale e del danno d'organo successivi a terapia antibiotica
US20080268039A1 (en) * 2007-03-06 2008-10-30 Soft Gel Technologies, Inc. Loquat compositions
US20080260873A1 (en) * 2007-04-23 2008-10-23 Fancl Corporation Agent for prevention or improvement of neuropathy comprising pre-germinated brown rice lipid fraction as an effective ingredient
US20090175973A1 (en) * 2007-09-05 2009-07-09 Nina Vikhrieva Coffee cherry compositions and methods for their use in the treatment of diabetes and diabetes related disorders
KR100912054B1 (ko) * 2007-09-12 2009-08-12 씨제이제일제당 (주) 미강 단백질 추출물의 제조 방법
US20090123580A1 (en) * 2007-10-17 2009-05-14 Nutracea Methods for treating obesity, insulin resistance and inducing satiety
US20090162513A1 (en) * 2007-12-20 2009-06-25 Leo Gingras Rice hull composition
US20090162514A1 (en) * 2007-12-21 2009-06-25 Leo Gingras Production of pasta using rice bran and rice flour
KR100863524B1 (ko) * 2007-12-28 2008-10-15 주식회사 뉴젝스 영릉향 추출물을 유효성분으로 함유하는 대사성 질환의예방 및 치료용 조성물
TW200950796A (en) * 2008-05-18 2009-12-16 Rice Science Llc Rice bran extracts for inflammation and methods of use thereof
US20100015306A1 (en) * 2008-07-15 2010-01-21 Pepsico, Inc. Method for Preparing a Low Viscosity Whole Grain Flour Slurry
US20100178400A1 (en) * 2009-01-13 2010-07-15 Pepsico, Inc. Method of Preparing a Whole Grain Beverage
US8197866B1 (en) * 2009-03-19 2012-06-12 Maria Lukacs Herbal treatment for diabetes mellitus, type II
US9192180B2 (en) * 2010-09-15 2015-11-24 Paul Raymond Reising Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same
US8945642B2 (en) 2010-09-15 2015-02-03 Ike E. Lynch Nutritionally enhanced isolate from stabilized rice bran and method of production
US11540546B2 (en) * 2010-09-15 2023-01-03 Quintessence Nutraceuticals, LLC Nutraceuticals for the management of conditions related to type 2 diabetes
US11547135B2 (en) * 2010-09-15 2023-01-10 Quintessence Nutraceuticals, LLC Mitigation of chronic infant malnutrition
WO2012138146A2 (ko) * 2011-04-08 2012-10-11 주식회사 케이오씨바이오텍 돌콩의 열처리분말 또는 추출물을 유효성분으로 하는 당뇨병 및 당뇨합병증의 예방 및 치료를 위한 조성물
EP2583562A1 (de) * 2011-10-21 2013-04-24 Nestec S.A. Verwendung von Molkeproteinmizellen für Kinder mit Adipositas- oder Diabetesrisiko
MX366970B (es) * 2012-07-03 2019-08-01 Zeller Max Soehne Ag Nuevo uso farmacologico de extracto de cimicifuga.
US20140335123A1 (en) * 2013-04-25 2014-11-13 Kyoungsik Pak Food Composition and Uses for Diabetes
WO2014204853A1 (en) * 2013-06-19 2014-12-24 Access Business Group International Llc Plant-based inhibitors of ketohexokinase for the support of weight management
JP2015086153A (ja) * 2013-10-29 2015-05-07 株式会社ファンケル Ｖｌｄｌ分泌抑制剤
JP6313627B2 (ja) * 2014-03-28 2018-04-18 株式会社ファンケル アシル化ステロール配糖体を含有する粉末状又は固形状組成物及び製造方法
EP3277269A4 (de) * 2015-04-02 2018-11-14 Omniactive Health Technologies Ltd. Verfahren zur prävention und behandlung von kardiometabolischem syndrom und zusammensetzungen dafür
JP6847457B2 (ja) * 2017-08-09 2021-03-24 国立大学法人信州大学 高圧加工米および該高圧加工米を含む食品用または医薬用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117096A (en) 1978-02-27 1979-09-11 Masahisa Takeda Brewing of alcoholic drink
JPH0723315B2 (ja) 1986-02-28 1995-03-15 日本食品化工株式会社 血糖値上昇抑制物質
JPS6466203A (en) 1987-09-07 1989-03-13 Hiroshi Hikino Polysaccharide, isolation and use thereof
JPH01294631A (ja) 1988-05-19 1989-11-28 Sanwa Kagaku Kenkyusho Co Ltd 糖尿性疾患治療予防剤及び飲食、し好物
JPH01310663A (ja) 1988-06-09 1989-12-14 Sanwa Kagaku Kenkyusho Co Ltd 米糠由来の組成物、該組成物を含有する動物用消臭剤及びその製法
JPH0678367B2 (ja) 1990-05-15 1994-10-05 呉羽化学工業株式会社 食物繊維、その製造法及びその食物繊維を含有する生理活性剤
US5514398A (en) 1990-11-05 1996-05-07 Amano Pharmaceutical Co., Ltd. Food additive and use thereof
US5153019A (en) 1991-05-30 1992-10-06 University Research & Marketing, Inc. Rice bran-honey based beverage product and process for making same
CA2124086A1 (en) 1991-11-22 1993-05-27 Ronald H. Lane Tocotrienols and tocotrienol-like compounds and methods for their use
US5292537A (en) 1992-11-12 1994-03-08 Bran Tec, Inc. Method for stabilizing rice bran and rice bran products
US5843921A (en) 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
JP4838920B2 (ja) * 1997-04-02 2011-12-14 株式会社創研 米からの糖尿病予防・治療剤

Also Published As

Publication number Publication date
CA2305665C (en) 2011-12-06
AU9210998A (en) 1999-03-16
EP1011702A4 (de) 2004-01-21
WO1999010002A1 (en) 1999-03-04
BR9811426A (pt) 2002-02-13
EP1011702B1 (de) 2011-11-02
MXPA00002122A (es) 2003-06-09
KR20010023528A (ko) 2001-03-26
AU751704B2 (en) 2002-08-22
NZ503648A (en) 2002-10-25
JP2001513571A (ja) 2001-09-04
KR100583211B1 (ko) 2006-05-24
US6303586B1 (en) 2001-10-16
CN1114438C (zh) 2003-07-16
CA2305665A1 (en) 1999-03-04
CN1278181A (zh) 2000-12-27
EP1011702A1 (de) 2000-06-28

Similar Documents

Publication Publication Date Title
ATE531381T1 (de) Stabilisierte reiskleiederivate zur behandlung von diabetes
ATE104380T1 (de) Sauerstoffdelignifizierung und enzymatische behandlung.
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
AU5729098A (en) Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
NO20052755L (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmate for dens fremstilling og dens anvendelse.
NO975693D0 (no) Rekombinant heksoseoksidase, fremgangsmåte for fremstilling av dette og anvendelse av et slikt enzym
DE69703649T2 (de) Behandlung von deagglomerierten teilchen mit plasmaaktivierter spezies
CA2308177A1 (en) Intravascular stent and method for manufacturing an intravascular stent
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
TR200101549T2 (tr) p53-Familyasından bir proteinin yapısal kararlılığının canlandırılmasına yönelik metotlar.
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
WO1998028411A3 (en) Enlarged cellulase compositions for use in the treatment of textiles
TR199501643A2 (tr) Yünün enzimlerle tedavisi icin yöntem.
DE3852116D1 (de) Herstellung von Proteinen in aktiver Form.
MY117526A (en) N-(3-benzofuranyl)urea-derivatives
WO2003102016A3 (en) Amyloid peptide inactivating enzyme to treat alzheimer's disease
SE8902532L (sv) Bestaemning av plasmaproteiner
ATE513056T1 (de) Stabilisierte proteine
DE69804659T2 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE60012517D1 (de) Methoden zur behandlung von diabetes
DE69940980D1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE59008012D1 (de) Mittel zur Behandlung von Leder und Pelzen.